Meanwhile, low Prrx1 expression is significantly associated with poor prognosis in various digestive system tumours, including colorectal cancer [31], gastric cancer [32], and HCC [33, 34]. This evidence concerns the gene PRRX1 and hepatocellular carcinoma.